Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 164

    Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company

    Glenmark Pharma appoints Alessandro Riva as CEO of its new innovation company

    Farhat Nasim7 March 2019 9:00 AM IST
    Alessandro Riva also worked in companies including Novartis, Rhone-Poulenc Rorer and Aventis, France.New Delhi: Drug major Glenmark Pharmaceuticals...
    Smuggling of anti cancer drug in India worth Rs 1.23 crore, Chinese arrested at airport

    Smuggling of anti cancer drug in India worth Rs 1.23 crore, Chinese arrested at airport

    Farhat Nasim6 March 2019 1:45 PM IST
    Schedule H drugs are prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs...
    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Alembic Pharma JV Aleor gets USFDA nod for Clobetasol Propionate ointment

    Farhat Nasim6 March 2019 9:45 AM IST
    The company's JV, Aleor Dermaceuticals Ltd, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug...
    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Farhat Nasim6 March 2019 9:30 AM IST
    Imatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
    Zydus Cadila gets USFDA nod to Rivastigmine transdermal system, Rosuvastatin

    Zydus Cadila gets USFDA nod to Rivastigmine transdermal system, Rosuvastatin

    Farhat Nasim6 March 2019 9:15 AM IST
    Rivastigmine transdermal system and Rosuvastatin will be manufactured at the group's formulations manufacturing facility at SEZ in Ahmedabad, Zydus...
    CHMP recommends Sanofi Zynquista for treatment of adults with type 1 diabetes

    CHMP recommends Sanofi Zynquista for treatment of adults with type 1 diabetes

    Farhat Nasim6 March 2019 9:00 AM IST
    Sanofi and Lexicon developed Sotagliflozin is also currently being reviewed by the U.S. Food and Drug Administration (FDA) and has the potential to be...
    Zydus Cadila gets USFDA nod to Doxazosin for treating BP, enlarged prostate issues

    Zydus Cadila gets USFDA nod to Doxazosin for treating BP, enlarged prostate issues

    Farhat Nasim5 March 2019 4:52 PM IST
    Doxazosin is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia, it added. New Delhi: Gujarat based...
    Glenmark Pharma gets USFDA nod for generic version of Micardis HCT tablets

    Glenmark Pharma gets USFDA nod for generic version of Micardis HCT tablets

    Farhat Nasim5 March 2019 10:15 AM IST
    The approved products is a generic version of Boehringer Ingelheim Pharmaceuticals Inc's Micardis HCT tablets. MICARDIS HCT (telmisartan and...
    OxyContin maker Purdue Pharma exploring bankruptcy: Report

    OxyContin maker Purdue Pharma exploring bankruptcy: Report

    Farhat Nasim5 March 2019 9:20 AM IST
    Sales of OxyContin and other opioids have fallen amid public concern about their addictive nature, and as restrictions on opioid prescribing have been...
    Eli Lilly offers generic version of insulin Humalog at half price

    Eli Lilly offers generic version of insulin Humalog at half price

    Farhat Nasim5 March 2019 9:15 AM IST
    The price of Lilly’s Humalog rose from $35 to $234 per dose between 2001 and 2015, a 585 per cent increase, the senators, Republican Chuck Grassley...
    Glenmark Pharma announces progress in its eczema drug investigation

    Glenmark Pharma announces progress in its eczema drug investigation

    Farhat Nasim5 March 2019 8:59 AM IST
    GBR 830 is an investigational, anti-OX40 monoclonal antibody being studied for the treatment of moderate-to-severe atopic dermatitis (AD).PARAMUS:...
    Orchid Pharma Insolvency Case: Ingen Capital CEO warned of arrest

    Orchid Pharma Insolvency Case: Ingen Capital CEO warned of arrest

    Garima4 March 2019 2:00 PM IST
    Chennai: In a major setback to Ingen capital, the National Company Law Appellate Tribunal (NCLAT) has called for a response to a show cause notice...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Abbott CEO Miles D White to step down in 2020, Robert B Ford to take over

    Abbott CEO Miles D White to step down in 2020, Robert B Ford to take over

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok